Mei Ri Jing Ji Xin Wen·2025-07-02 11:13Core Viewpoint - Significant shareholding increases by major shareholders in listed companies reflect confidence in the market, with June 2025 seeing a record high in total share buybacks in the A-share market [1][2]. Group 1: Shareholder Buybacks - In June 2025, the total value of shares bought back by major shareholders in A-shares reached 104.83 billion yuan, the highest in nearly three years, significantly surpassing the 33.77 billion yuan in May and 69.85 billion yuan in the same month last year [2][4]. - The net buyback value in June was 49.72 billion yuan, marking the highest net buyback in nearly a year and nearly five times the second-highest month in the past year [4][5]. - A total of 211 listed companies had ongoing buyback plans, with the mechanical equipment sector leading with 17 companies, followed by public utilities and basic chemicals, each with 16 companies [5][6]. Group 2: Industry Performance - The industries with the most significant shareholder buybacks included mechanical equipment, public utilities, basic chemicals, pharmaceutical biology, and petroleum and petrochemicals [1][5]. - Notable companies with substantial buybacks included Tongfeng Electronics, Dahu Co., and China General Nuclear Power, with estimated buyback ratios leading the market [6][7]. Group 3: Individual Company Highlights - Copper Peak Electronics reported a 16.72% year-on-year increase in revenue for Q1 2025, with a net profit growth of 12.53% [8]. - Zhongman Petroleum saw a 15.51% increase in stock price in June, with its controlling shareholder planning to buy back shares worth 180 million to 360 million yuan [8]. - Debon Holdings experienced a significant drop of 22.08% in stock price despite a previous surge, indicating volatility in response to shareholder actions [9]. Group 4: New Buyback Plans - In June, 16 companies announced new buyback plans, with Huate Dain leading with a 3.70% buyback ratio, which was also the highest stock price increase among these companies at 17.47% [11][12]. - Qianhong Pharmaceutical's controlling shareholder completed a buyback of 1.72% of shares within a week of announcing the plan [12][13].